Tag: Ranbaxy Laboratories
Foreign pharma threat could spur new FDI cap
India may cut FDI in pharmaceuticals to 49% to protect local companies
India may cut FDI in pharmaceuticals to 49% to protect local companies
Shared venture documentation gaps slow India funding rounds and shape foreign capital perceptions of ecosystem maturity
Follow us on LinkedIn